Herculink Elite Rapid Exchange Renal Stent System

Deliverability and Reliability

Excellent strength, visibility, and deliverability to the renal arteries.

Outstanding design

  • Rapid exchange delivery system for single-operator use
  • 6F guide compatibility for all stent diameters (4 mm - 7 mm) and lengths (12 mm, 15 mm, 18 mm)
  • Cobalt chromium multi-link technology that provides strength and excellent visibility
  • Remarkably thin struts with outstanding radial strength

Outstanding performance1

  • 74.3% of patients had a reduction in systolic blood pressure at 3 years
  • 10.5% restenosis at 9 months

Low Restenosis1


Primary Endpoint

Mean SBP Reduced at 1 Month and Remained Low at 3 Years1

 

Excellent Freedom from TLR1

Reduced Systolic Blood Pressure

74.3% of patients had a reduction in systolic blood pressure at 3 years1

Stent Compliance Label (CE)

Ordering information

RX Herculink Elite™ Renal Stent System
Stock Number
Catheter Length
Stent Diameter (mm)Stent Length (mm)Sheath Compatibility (F)Inflation Pressure (ATM)
Nominal/RBP
Max Post-Dilation Diameter (mm)
80 (cm) 135 (cm) 
1011521-12 1011522-124.012511 / 147
1011521-151011522-154.015511 / 147
1011521-181011522-184.018511 / 147
1011524-121011525-124.512511 / 147
1011524-151011525-154.515511 / 147
1011524-181011525-184.518511 / 147
1011527-121011528-125.012511 / 147
1011527-151011528-155.015511 / 147
1011527-181011528-185.018511 / 147
1011530-121011531-125.512511 / 147
1011530-151011531-155.515511 / 147
1011530-181011531-185.518511 / 147
1011533-121011534-126.012511 / 147
1011533-151011534-156.015511 / 147
1011533-181011534-186.018511 / 147
1011536-121011537-126.512511 / 148
1011536-151011537-156.515511 / 148
1011536-181011537-186.518511 / 148
1011539-151011540-157.015511 / 148
1011539-181011540-187.018511 / 148

 


 

Discover Abbott’s Peripheral intervention technology


 

Abbott’s Peripheral Intervention Portfolio

Data on file at Abbott.

References

  1. Chrysant, George S., et al. Proper Patient Selection Yields Significant and Sustained Reduction in Systolic Blood Pressure Following Renal Artery Stenting in Patients With Uncontrolled Hypertension: Long-Term Results From the HERCULES Trial. The Journal of Clinical Hypertension, 2014 July.

 

MAT-2117132 V1.0